PI Industries' steady Q3FY25 performance, cautious near-term outlook, and portfolio challenges are likely to affect the ...

Supermicro has taken steps to put everything back on track, though, and this week, as it reported its latest unaudited ...

Eli Lilly continues to see strong growth coming from its GLP-1 drugs. The company's current 2025 guidance looks conservative.

Official figures showed gross domestic product edged 0.1% higher between October and December, confounding expectations for a ...

While Karnataka may not turn into a no-go zone for microfinance lenders, industry executives caution that, in the near-term, ...